GSK returns rights to Wave's RNA editing program for AATD
葛兰素史克将 Wave 针对 AATD 的 RNA 编辑项目权益归还给该公司

GSK no longer plans to collaborate on a closely-watched RNA editing program from Wave Life Sciences, whose fate could influence the prospects of the emerging field.
葛兰素史克不再计划参与与 Wave Life Sciences 合作的一项备受关注的 RNA 编辑项目，该项目的命运可能会影响这一新兴领域的前景。